Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
1.04%
$0.93
$89.98
01:16 25/03/17
$89.98
01:16 25/03/17
DAILY VARIATION
1.04%
$0.93
VOLUME
1,064,364
DATA
52 Week High
$102.83
52 Week Low
$72.02
Shares Issued
248.44m
Market Cap
$22,354.46m
RiskGrade
128
Beta
1.70
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% 5.7%
ROCE 0.0%
Latest F'cast
P/E -39.0 5,453.3
PEG 0.0 0.6
Pr/Revenue 21.7 11.2
Pr/Book 20.4
Latest F'cast
Revenue 77.9% -37.0%
PBT 0.0% n/a
EPS 0.0% -70.3%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 -231.00¢ -54.5 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,702.17 -68.29 85.00c 10,585.9 n/a 0% 0.00c 0.0%
2017-12-31 1,995.28 113.16 159.23c 5,453.3 62.4 87% 0.00c 0.0%
2018-12-31 2,543.06 573.46 297.95c 3,019.5 34.7 87% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found